Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep1106 | Late Breaking | ECE2023

Diabetes treatment with dapagliflozin and its combinations: Insights from clinical practice

Mehta Ajit , Bafna Akshay , Goel Sandeep , Trivedi A.K. , Mishra Chandrakanta , Naik Preethi , Zalte Nitin , Sugumaran Amarnath

Background: Despite global guidelines recommending initiation of SGLT2i drugs like dapagliflozin in type 2 diabetes (T2DM) patients with cardiovascular (CV) or renal risk, its clinical translation is still lacking in India.Objective: To understand cliniciansÂ’ perspectives regarding the association of CV risk and T2DM in Indian patients, and the need for the use of combination therapies with dapagliflozin in T2DM patients, in Indian clinical practice...